Basic Information
Basic information for CCDC26-233-19aa-2
Peptide Name CCDC26-233-19aa-2
Genome Position chr8:129352273-129352329[-]
Species Human
Peptide Sequence MLEIICKLASVGVWNIVGF
Peptide Length 19
Unique No (CCDC26-201-19aa-2,CCDC26-205-19aa-1,CCDC26-217-19aa-2,CCDC26-228-19aa-2,CCDC26-231-19aa-2,CCDC26-236-19aa-2,CCDC26-237-19aa-2,CCDC26-245-19aa-2,CCDC26-246-19aa-1,CCDC26-247-19aa-1,CCDC26-254-19aa-1,CCDC26-262-19aa-2,CCDC26-263-19aa-2,CCDC26-264-19aa-2,CCDC26-268-19aa-2,CCDC26-277-19aa-2,CCDC26-280-19aa-1)
Grand Average of Hydropathicity 1.5421
Relative Molecular Mass 2416.84
Experimental Evidences no
lncRNA ID/Name ENSG00000229140;CCDC26
Transcript ID/Name ENST00000658861;CCDC26-233
Transcript Length 1741
Coding Ability 0.2516
DNA Sequence Corresponding to Peptide ATGTTGGAAATTATATGCAAATTGGCTTCCGTTGGTGTTTGGAACATAGTAGGTTTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :